Delivery Order SPE2DB22D3004-SPE2DB24FRA45

Award Date 7/11/24
Potential Completion Date 8/1/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the delivery of the prescription drug Orgovyx 120 mg tablets. The contract has a ceiling value of $2,659.78 and a period of performance through July 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,329.89, is for the delivery of the pharmaceutical product Orgovyx 120 mg Tablet, with a performance period ending in August 2024. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orgovyx 120 mg tablets. The $2,659.78 firm-fixed-price contract has an ultimate completion date of October 9, 2024. This award is not set-aside for any specific business type. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,313.12, is for the delivery of Orgovyx 120 mg tablets over a period ending on June 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract is for the medication Orgovyx 120 mg tablet, with a completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,385.52 for the provision of the drug Orgovyx 120 mg tablets. The contract is under the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, with ID SPE2DB24D2018|SPE2DB25FWUH1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orgovyx 120 mg tablets. The contract has a ceiling value of $1,385.52 and a period of performance through May 19, 2025. This appears to be a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,385.52, is for the pharmaceutical product Orgovyx 120 mg tablets. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx 120 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 16, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Orgovyx 120 mg tablet. The contract has a ceiling value of $1,385.52 and a period of performance through April 28, 2025. This contract is not designated as a set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRA45
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the prescription drug Orgovyx 120 mg tablets. The contract has a ceiling value of $1,329.89 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/10/24, 9:15 AM